We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-5.58%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$11.8B
AUM Growth
-$1.61B
Cap. Flow
-$540M
Cap. Flow %
-4.58%
Top 10 Hldgs %
8.82%
Holding
1,043
New
77
Increased
349
Reduced
381
Closed
85

Top Buys

Rank Stock Value
1
ZD icon
Ziff Davis
ZD
+$62.7M
2
LPX icon
Louisiana-Pacific
LPX
+$24.3M
3
FWRD icon
Forward Air
FWRD
+$20.6M
4
AVLR
Avalara, Inc.
AVLR
+$19.2M
5
RGEN icon
Repligen
RGEN
+$17.1M

Sector Composition

Rank Sector Weight
1 Industrials 26%
2 Technology 19.36%
3 Financials 13.64%
4 Consumer Discretionary 13.09%
5 Materials 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEU icon
676
NewMarket
NEU
$7.97B
$2.6M 0.02%
8,000
RGLD icon
677
Royal Gold
RGLD
$17.2B
$2.53M 0.02%
17,900
+6,300
+54% +$736K
ATIP
678
DELISTED
ATI Physical Therapy, Inc.
ATIP
$2.52M 0.02%
26,836
+12,682
+90% +$1.61M
ITI
679
DELISTED
Iteris, Inc.
ITI
$2.52M 0.02%
844,474
-315,000
-27% -$1.09M
GTYH
680
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$2.51M 0.02%
778,415
+75,372
+11% +$349K
CRNT icon
681
Ceragon Networks
CRNT
$197M
$2.51M 0.02%
1,178,056
-580,174
-33% -$1.27M
MAG
682
DELISTED
MAG Silver
MAG
$2.49M 0.02%
154,050
-198,900
-56% -$3.17M
MRIN
683
DELISTED
Marin Software
MRIN
$2.47M 0.02%
142,738
+21,589
+18% +$418K
WST icon
684
West Pharmaceutical
WST
$23.9B
$2.46M 0.02%
6,000
HY icon
685
Hyster-Yale Materials Handling
HY
$600M
$2.46M 0.02%
74,054
-70,000
-49% -$2.77M
EMKR
686
DELISTED
Emcore Corp
EMKR
$2.42M 0.02%
65,435
+2,030
+3% +$97.2K
LPTH icon
687
Lightpath Technologies
LPTH
$648M
$2.42M 0.02%
1,228,084
+10,000
+0.8% +$22.7K
CZWI icon
688
Citizens Community Bancorp
CZWI
$211M
$2.41M 0.02%
159,691
+6,185
+4% +$93K
CSIQ icon
689
Canadian Solar
CSIQ
$1B
$2.4M 0.02%
68,000
ATR icon
690
AptarGroup
ATR
$8.54B
$2.4M 0.02%
20,396
VERI icon
691
Veritone
VERI
$97.6M
$2.38M 0.02%
130,000
TMDX icon
692
Transmedics
TMDX
$2.63B
$2.34M 0.02%
87,000
+26,000
+43% +$466K
ATLO icon
693
AMES National
ATLO
$269M
$2.31M 0.02%
93,030
-18,900
-17% -$462K
FISI icon
694
Financial Institutions
FISI
$812M
$2.29M 0.02%
75,893
-15,089
-17% -$485K
FOCS
695
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$2.29M 0.02%
50,000
TREE icon
696
LendingTree
TREE
$445M
$2.27M 0.02%
19,000
-5,050
-21% -$597K
WK icon
697
Workiva
WK
$3.29B
$2.24M 0.02%
+19,000
New +$2.1M
BCC icon
698
Boise Cascade
BCC
$2.65B
$2.22M 0.02%
31,996
-2,350
-7% -$177K
WSFS icon
699
WSFS Financial
WSFS
$4.1B
$2.21M 0.02%
47,382
+34,669
+273% +$1.8M
CAC icon
700
Camden National
CAC
$977M
$2.17M 0.02%
46,217
-12,553
-21% -$620K

Similar funds

Royce & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Royce & Associates held 1,043 positions worth $11.8B, down 12% from $13.4B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Royce & Associates withdrew a net $540M in Q1 2022, closing 85 positions and reducing 381 holdings. Its most notable exit was Canada Goose Holdings, an estimated $21.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Avalara, Inc. worth $18.9M.

  • Royce & Associates's largest Q1 2022 buy was Avalara, Inc.: 189,630 shares worth $18.9M.
  • Royce & Associates added most to Ziff Davis in Q1 2022, an estimated $62.7M increase.
  • Royce & Associates's biggest Q1 2022 reduction was CMC Materials, Inc. Common Stock, cutting an estimated $42.4M.
  • Royce & Associates fully exited Canada Goose Holdings in Q1 2022, selling an estimated $21.3M.
  • Royce & Associates's ten largest holdings make up 8.8% of its $11.8B portfolio in Q1 2022.
  • Royce & Associates opened 77 new positions and closed 85 in Q1 2022.
  • Royce & Associates's portfolio value fell 12% quarter-over-quarter to $11.8B.

Based on Royce & Associates's 13F filing for Q1 2022, filed 5 May 2022.